Tourette's syndrome and its borderland.
Tourette's syndrome and its borderland.
复制标题
DOI:
10.1136/practneurol-2017-001755
复制
发表时间:
2018-08-01
影响因子:
2.8
通讯作者:
Stern, Jeremy S
中科院分区:
文献类型:
--
作者:
Stern, Jeremy S
The Gilles de la Tourette syndrome (or Tourette's syndrome) has a prevalence of 1% of children with a wide range of severity and associated comorbidities. The last 20years have seen advances in the understanding of the syndrome's complex genetics and underlying neurobiology. Investigation with imaging and neurophysiology techniques indicate it is a neurodevelopmental condition with dysfunction of basal ganglia-cortical interactions, which are now also being studied in animal models. There is also increasing evidence for treatments although it often remains difficult to manage. First-line options include neuroleptics, other drugs and specialised behavioural treatments. Deep brain stimulation is an evolving field, not yet fully established. This review focuses on the phenomenology of tics, how to assess and manage the syndrome, and uses examples of atypical cases to explore the characteristics and limits of its clinical spectrum.